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Abstract 
 
HIV and AIDS are among the world’s pandemics that pose serious concern to almost every 
individual in the world. With the current level of availability of anti-retroviral (ARV) drugs 
and the ease of accessibility of treatment in many countries such as South Africa, the disease 
can be controlled by suppressing the viral load of an infected individual. These anti HIV 
drugs such as delavirdine are metabolised by enzymes which are found in the liver 
microsomes, particularly those of the cytochrome P450 family. Due to the fact that the 
metabolic rate of a patient determines the effect of the drug, the drug could either have a 
beneficial or an adverse effect once it is administered. It is therefore imperative that the 
metabolic profile of a patient is determined at point-of-care is necessary for proper dosing of 
the ARV drugs. In this project a nanobiosensor system was devised and used for the 
determination of the metabolism of delavirdine, a non nucleoside reverse transcriptase 
inhibitor (NNRTI) ARV drug. The nanobiosensor was prepared by the entrapment of the 
isoenzyme CYP3A4 into a pre-formed electro active carrier matrice consisting of a 
dendrimeric copper generation-2 poly(propylene imine)-co-polypyrrole star copolymer  
(Cu(G2PPI)-co-PPy).  The metallo-dendrimer was used as a host for the enzyme and 
provided the necessary bio-compatible environment that allowed the direct transfer of 
electrons between the enzyme’s active centres and platinum electrode surface. Copper was 
the choice of metal used in the study due to its properties. Copper is a malleable, ductile and a 
good conductor of both heat and electricity. It is a better conductor than most metals. Silver 
which also belongs to group 1b in the periodic table is a better electrical conductor than 
copper but copper has better corrosion resistance and is a more abundant and hence it is a 
cheaper material to use.  Cu(G2PPI)-co-PPy was prepared by the incorporation of the copper 
metal into the G2PPI and the electropolymerization of pyrrole onto the Cu(G2PPI). The 
incorporation of Cu into G2PPI was determined by FTIR which did not show the presence of 
the Cu but showed an increase in the intensities of the peaks after the incorporation. The 
surface morphology of Cu(G2PPI) was confirmed by the use of HRSEM which showed a 
difference in the surface morphology of the dendrimer moiety with the addition of the copper 
metal. The HRSEM images after Cu incorporation resulted in the change from rough surface 
to smooth surface with open cavities which were essential for the entrapment of the 
biological systems (CYP3A4). Energy dispersive spectrometry (EDS) and HRTEM were 
used to confirm the presence of spherically shaped copper nanoparticles in the Cu(G2PPI) 
and were found to have a size distribution of 12-17 nm with an average particle size of 15 
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nm. The star copolymer (Cu(G2PPI)-co-PPy) was characterised using cyclic voltammetry 
where it was confirmed that the material was electroactive and conducting due to electron 
movement along the polymer chain. A diffusion co-efficient (Do) value of 8.64 x 10
-5
 cm
2
/s 
was determined for the material indicating a slow electron transfer kinetics within the 
diffusion layer. The constructed nanobiosensor was developed using copper poly(propylene 
imine) – polypyrrole star copolymer, bovine serum albumin and glutaraldehyde coupled to 
the enzyme CYP3A4. The resultant nanobiosensor parameters include a dynamic linear range 
(DLR) of 0.01-0.06 nM, a limit of detection (LOD) of 0.025 nM and a sensitivity value of 
0.379 μA/nM. 
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1.0 Summary  
 
 
This chapter gives a brief overview on the background of the human immunodeficiency virus 
(HIV) and its life cycle, the process of anti-retroviral treatment (ART) and a description of 
anti retroviral drugs. This chapter also includes the problem statement, motivation, aim and 
objectives and the outline of this document. 
 
Background 
 
Human immunodeficiency virus (HIV) is a retrovirus that leads to the formation of acquired 
immunodeficiency syndrome commonly known as AIDS. HIV attacks the cells of the body 
that are required for protection against foreign substances such as diseases. During HIV 
infection, the virus attacks and destroys the infection-fighting CD4 cells of the body’s 
immune system. CD4 cells are T helper lymphocytes which are white blood cells that help 
the immune system to coordinate the attack of foreign organisms (Cornell, 1997). Although 
the HIV virus is able to infect a variety of cell types, acquired immunodeficiency syndrome 
(AIDS) results from the depletion of CD4+ T-Helper lymphocyte cells, a key component of 
the human immune system. The envelope (env) gene encodes the proteins of the outer 
envelope of the virus, the group-specific antigen (gag) gene encode the components of the 
inner capsid protein, whereas the polymerase (pol) gene codes for the enzymes such as 
Reverse transcriptase that are used in viral replication. Even though it mostly attacks these 
cells it also affects other cells of the body in order to stay in a dominant phase. HIV makes 
copies of itself and infects other cells by using the CD4 cells as the host cells. This process 
causes a reduction of CD4 cell thus weakening the immune system against infections. The 
time taken for the HIV virus to progress to AIDS varies with each person. Therefore, may 
take a couple of years before HIV develops to AIDS (Crumbliss, 1992). 
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Figure 1: Key aspects of the HIV life cycle (Kirchheiner, 2007). 
 
The virus can be transmitted from one person to another through infected blood, semen or 
vaginal secretion in contact with an infected person’s broken skin or mucous membranes (a 
mucous membrane is wet, thin tissue found in certain openings to the human body). In 
addition, pregnant women who are infected can transmit the virus to their baby during 
pregnancy or during the course of delivery and/or during breast feeding. Once the virus is 
transmitted through any of the above mentioned measures it enters the body and binds to the 
CD4+ cell through its protein envelope on the surface of the host cell. The HIV envelope and 
the CD4 cell membrane fuse together allowing the penetration of the virus into the CD4 cell. 
Once inside the cell, HIV releases an HIV enzyme called reverse transcriptase which it used 
for the conversion of its genetic material from HIV RNA to HIV DNA. This conversion is 
necessary so that HIV can enter the nucleus of the CD4 cell and combine with its genetic 
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material. HIV produces an enzyme called integrase whose function is to allow the HIV DNA 
to enter the CD4 cell nucleus; once inside it integrates with the CD4 cell DNA. Once HIV is 
integrated into the DNA of the cell it uses the machinery of the CD4 cell to make long chains 
of the HIV protein which are the building blocks for HIV duplication. The long chains are cut 
into smaller chains by an enzyme known as protease, the combination of the smaller proteins 
forms a new virus, and the newly formed HIV virus exits within the cell, this process is 
known as the HIV life cycle and is described in Fig.1 (Kirchheiner, 2007). 
 
HIV is a world pandemic where the number of people affected by the disease is constantly 
increasing each year. At the end of 2013, there were 35 million [33.2 million–37.2 million] 
people living with HIV. This number is increasing as more people are living longer because 
of antiretroviral therapy, alongside the number of new HIV infections-which, although 
declining, is still very high. An estimated 0.8% [0.7–0.8%] of adults aged 15–49 years 
worldwide are living with HIV, although the burden of the epidemic continues to vary 
considerably between regions and countries. There are 3.2 million [2.9 million–3.5 million] 
children younger than 15 years living with HIV and 4 million [3.6 million–4.6 million] young 
people 15–24 years old living with HIV, 29% of whom are adolescents aged 15–19 years. 
There are 16 million [15.2 million–16.9 million] women aged 15 years and older living with 
HIV; 80% live in sub-Saharan Africa. The primary contributor to the scale of the epidemic in 
this region is heterosexual transmission and the increased vulnerability to and risk of HIV 
infection among adolescent girls and young women.  
 
Of the 35 million people living with HIV, 24.7 million [23.5 million–26.1 million] are living 
in sub-Saharan Africa, the region hardest hit by the epidemic. Nearly one in every 20 adults is 
living with the virus in this region. Almost 4.8 million [4.1 million–5.5 million] people are 
living with HIV in Asia and the Pacific, although the regional prevalence of HIV infection is 
about one-seventeenth than in sub- Saharan Africa. In the Caribbean, 1.1% [0.9–1.2%] of 
adults were living with HIV at the end of 2013 (Rambaut, 2004).  
 
The most common problem with HIV is the fact that it has no cure. However there are drugs 
available that help with the drastic change in the progression time between the infection of 
HIV and its development into AIDS. The development of safe and effective drugs ensures 
that HIV positive people live a longer and healthy lives further increases their life expectancy 
(Belluzo, 2008). 
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The current drugs available do not cure HIV infections but they do however prevent the 
development of AIDS. The drugs do not eliminate the virus from the body but prevent the 
virus from being made in the body, stopping the virus from weakening and damaging the 
immune system (Xiao, 2013). As HIV attacks the CD4 cells, they deplete in number. This 
depletion in CD4 cells signifies the weakening of the immune system showing inability to 
fight opportunistic diseases and infections such as Tuberculosis (TB) and pneumonia. This 
means the immune system needs help so it can regain its strength and ability to fight off any 
infections or diseases. There are factors that determine the time a patient needs to start going 
into the anti-retroviral treatment. These factors include the CD4 count which determines the 
number of CD4 cells that are present in the blood which determines how well the immune 
system is working and the determination of the viral load which measures the amount of the 
HIV virus in the blood. Having a low CD4 count and a high viral load means that a patient 
needs to start taking the anti-retroviral drugs so they can increase the CD4 cell count and 
decrease the viral load (Bistolas, 2005).  
 
Anti-Retroviral Treatment (ART) is the recommended HIV treatment. It is a combination of 
different drugs that needs to be taken every day at the same time.  The combination ARV 
therapy prevents the HIV virus from multiplying inside a persons body. When the virus stops 
making copies of itself then the body's immune cells most notably the CD4 cells are able to 
live longer and provide the body protection from infections. HIV is an active virus and 
constantly makes copies of itself damaging the body’s immune cells. It can adapt very 
quickly to medicine by changing itself through gene mutation (Chemla, 2000). Taking a 
combination of different drugs at the same time in the same way ever day decreases the 
chances of the virus multiplying thus making the resistance of the virus to the drugs hard.  
Missing the medication increases the risks of resistance of the virus to the ART. The 
multiplication of the virus takes place inside an infected cell where the virus makes copies of 
itself and can infect other cells of the body. Anti-retroviral drugs interfere with the 
multiplication process and how it spreads to other cells (Boozer, 2003). 
  
There are different classes of HIV drugs. These include Nucleoside Reverse Transcriptase 
Inhibitors (NNRTIs): these drugs bind to and alter reverse transcriptase, an enzyme HIV 
needs to make copies of itself. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): 
NRTIs block reverse transcriptase, an enzyme HIV needs to make copies of itself.  Protease 
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Inhibitors (PIs): PIs block HIV protease, an enzyme HIV needs to make copies of itself. 
Fusion Inhibitors: Fusion inhibitors block HIV from entering the CD4 cells of the immune 
system. CCR5 Antagonists: CCR5 entry inhibitors block CCR5, a protein on the CD4 cells 
that HIV needs to enter the cells. Integrase Inhibitors: Integrase inhibitors blocks HIV 
integrase, an enzyme HIV needs to make copies of itself and Fixed-Dose Combination: 
Fixed-dose combination tablets contain two or more anti-HIV medications from one or more 
drug classes (Voorman, 1999). 
 
1.2 Problem statement 
 
HIV is a world pandemic which affects every individual (Rambaut, 2004). The availability of 
treatment to HIV infected patients has decreased the mortality rate caused by AIDS. The 
treatment manages to decrease the viral load and boosts the immune system. It fails to meet 
the individual required doses of patients. Even though there is availability of treatment which 
has decreased the mortality rate of HIV infected patients different individuals have different 
drug metabolic rates, this leads to the drug being ineffective to some individuals.  The most 
viable solution to this problem is the identification of poor, intermediate and rapid 
metabolizers through finding a rapid device that detects and quantifies the amount of drug in 
the human system after administration. 
 
1.3 Rational and motivation 
 
Sometimes there are different and undesired effects of certain drugs in different populations. 
This is particularly true for the drug having narrow therapeutic index. Often these different 
effects are detrimental to an individual, thus termed as adverse drug reactions. Many patients 
die from these adverse drug reactions and due to failure of the immune system they struggle 
to respond to the drug or poor administration of the drug. The other problem is that there is 
the fact that different individuals have different metabolic rates to drugs. There are three 
known types of metabolizers, rapid metabolizers, intermediate metabolizers and poor 
metabolizers. Metabolic rates depend mainly on cytochrome P-450 and N-acetyltransferase 
enzymes. Patients may be classified as fast, intermediate or slow metabolizers, depending on 
the activity levels of these enzymes. Poor metabolizers: have slow metabolic rates which 
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result in high drug plasma concentration. In case of fast/ ultrarapid metabolizers they have 
fast metabolic rates. Due to their fast metabolic rates the therapeutic effect may be 
diminished or absent (Varshney, 2012). 
 
It is common in medicinal and clinical practises to administer the same amount/ dose of drugs 
to all patients, leading to differences in the plasma concentrations of the drugs which 
correlates with the patients genotype. High drug concentration has detrimental effects on the 
patients as it causes concentration related central nervous system toxicity. Devising a 
nanobiosensor system which can be used for the monitoring of the metabolism of a drug such 
as delavirdine; a non nucleoside reverse transcriptase inhibitor will aid in determining the 
metabolic profile of a patient (Baselt, 1996). 
 
The techniques that are now available for the in vitro monitoring of antiretroviral drugs are 
time consuming, require large sample size and are relatively expensive. These techniques that 
are currently being used include liquid chromatography, mass spectrometry and high 
performance liquid chromatography. Thus there is an urgent need to develop new analytical 
tools that would be easy to use, capable of identifying substrates and inhibitors of an enzyme, 
and allow quantification of substrate turnover. The use of appropriate biosensor would be a 
welcome alternative, because they are generally of small size, capable of continuous 
measurements, and can measure analytes faster and at lower cost than traditional methods. 
This study reports the successful development of a nanobiosensor system on platinum 
surfaces using copper poly(propylene imine)–polypyrrole star copolymer coupled to 
CYP3A4 enzyme to determine the transformation of delavidine. 
 
1.4 Aim and objectives 
 
The aim of the study was to device a copper poly (propylene imine) star copolymer 
nanobiosensor for the determination of delavirdine. The nanobiosensors were developed on 
platinum surfaces using copper poly(propylene imine)–polypyrrole star copolymer, coupled 
to CYP3A4 enzyme using bovine serum albumin, glutaraldehyde. The objectives of this 
study were as follows; 
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 To functionalize G2 Poly(propylene imine) (PPI) with 2 Pyrrole (PPy).  
 To synthesize metallodendrimers by the incorporation of copper metal into 2-pyrrole 
functionalized poly (propylene imine) dendrimer. 
 To characterize the G2 (Polypropylene imine)-2 Pyrrole and copper (Cu) generation-2 
poly(propylene imine) to form Cu-PPI-PPy star copolymer. 
 To form  (Cu(G2PPI)-co-PPy)star copolymer by electropolymerisation of pyrrole onto the 
PPI/Pt. 
 To characterize  (Cu(G2PPI)-co-PPy)/Pt using CV. 
 To fabricate the nanobiosesor by immobilizing CYP 3A4/BSA and Glutaraldehyde onto  
(Cu(G2PPI)-co-PPy). 
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1.5 Thesis lay-out  
 
This thesis is presented in seven chapters  
Chapter 1: Gives a brief background information on the project, the problem statement, the 
motivation as well as aims and objectives of this study.  
Chapter 2: Provides a detailed literature review. 
Chapter 3: Consists of reagents, procedures and instrumentations used to achieve the  
success of this study.  
Chapter 4: Comprises of the results and discusiion by illustrating the morphological, 
spectroscopic as well as electrochemical results obtained from G2 PPI-2Py, Cu-PPI-2Py and 
(Cu(G2PPI)-co-PPy). 
Chapter 5: Provides electrochemical results obtained from the developed nanobiosensor as 
well as results obtained for the detection of the drug of interest. 
Chapter 6: Represents conclusion and recommendations. 
Chapter 7: References. 
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2.0 Summary  
 
This chapter covers the role of star copolymers and their applications in the field of sensors. 
Dendrimers, metallodendrimers and conducting polymers and the details of their 
composition and properties are discussed. Cytochrome P450 enzyme family and its isoform 
(CYP3A4) used in this study for successful enzyme electrode formation as well as a brief 
description of delavirdine (an NNRTI drug) and its pharmacokinetics are also presented. 
 
2.1 Drug metabolism 
 
Drug metabolism is a natural progression that involves the use of the enzymatic pathways and 
transport systems that are the same as the one used for the metabolism of consumed food 
constituents. The main purpose of drug metabolism is to make the drugs more water soluble 
so as to allow easy excretion through urine and bile. Drugs are considered to be xenobiotics 
meaning that they are regarded as substances that are foreign to the body and are widely 
metabolised in humans. The ability to metabolize xenobiotics, while mostly beneficial, has 
made development of drugs very time consuming and costly due to largely (1) interindividual 
variations in the capacity of humans to metabolize drugs, (2) drug-drug interactions, and (3) 
species differences in expression of enzymes that metabolize drugs. The latter limits the use 
of animal models in drug development. The vast difference in metabolism of xenobiotics by 
different species hence animal models cannot be relied upon for the prediction and 
determination of the ability of humans to metabolise a drug (Cornell, 1997). Xenobiotics are 
metabolised by enzymes, these enzymes are commonly known as the drug-metabolising 
enzymes even though they are involved in the metabolism of different chemicals to which 
humans are exposed. Consumption or exposure to xenobiotics in the absence of metabolism 
will result in their accumulation in the body due to lack of efficient elimination thus resulting 
in toxicity (Carr, 2010). 
 
There are three kinds of metabolizers, rapid metabolizers, slow metabolizers and intermediate 
metabolizers and they are characterised by their metabolic rates. Metabolic rates depend 
mainly on cytochrome P-450 and N-acetyltransferase enzymes. They may also differ due to 
drug interactions. Most commonly, this occurs when two drugs are co administered and are 
metabolized by the same enzyme. Patients may be classified as fast or slow metabolizers, 
depending on the activity levels of these enzymes. Some variants are slow metabolizers while 
others are ultra-rapid metabolizers. Slow metabolizers may be exposed to the active product 
 
 
 
 
11 
 
for longer than ultra-rapid metabolizers, or have greatly diminished exposure to the active 
metabolite. Conversely, ultra-rapid metabolizers risk longer exposure to the metabolite and 
much shorter exposure to the administered medication. Usually drug is inactivated by the 
P450 and poor metabolizers have higher blood level of drug and enhanced drug toxicity. It 
can result in loss of action of the prodrug or in toxicity due to the increase in metabolism of 
another pathway leading to a toxic product; as well as can have the important interactions 
leading to toxic response if combination of drugs metabolized by P450 is used (Crumbliss, 
1996). 
 
The ideal metabolisers being the intermediate metabolisers have the ability to metabolise 
drugs in a normal or ideal rate. The problem with the administration of drugs is that the given 
dosage is ideal for the intermediate metabolisers and does not take into consideration of the 
rapid and slow metabolisers. The slow and ultra rapid metabolisers then stand the risk of the 
drug not working properly. In the case of rapid metabolisers the drugs will only be available 
in extremely small amounts in the blood stream and the slow metabolisers run the risk of drug 
toxicity due to over accumulation of the drugs in the blood stream (Ingelman-Sundberg, 
2007). 
 
There are enzymes responsible for drug metabolism and these enzymes are referred to as the 
drug metabolising enzymes. Majority of the metabolizing enzymes fall under the cytochrome 
P450 family; the enzymes of this family are capable of catalyzing the oxidative 
biotransformation of most drugs and other lipophilic xenobiotics. There are many enzymes 
found in the cytochromeP450 family but only a dozen of enzymes belonging to the 1, 2, and 
3 CYP-families are responsible for the metabolism of the majority of drugs and other 
xenobiotics. Despite the broad and overlapping substrate specificities of these enzymes, many 
drugs are metabolized at clinically relevant concentrations by one or few enzymes only, 
which limits the important redundancy of the phase I drug oxidation system (Kirchheiner, 
2007).  
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2.2 Delavirdine drug 
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Figure 2: Structure of delavirdine 
 
Delavirdine (brand name rescriptor) whose structure is shown in Fig.2 is a prescription 
medicine used to treat HIV. It contains delavirdine mesylate (its chemical name is piperazine) 
a synthetic non-nucleoside reverse transcriptase inhibitor (NNRTI) of the human 
immunodeficiency virus. For oral administration each rescriptor tablet contains 100-200 mg 
of delarvidine mesylate hence it is referred to as delavirdine (Zanger, 2013). It is converted to 
several inactive metabolites. It is primarily metabolised by cytochrome P4503A4, but invitro 
information shows that it can also be metabolised by cytochrome P4502D6. The major 
metabolic pathways are N-desalkylation and pyridine hydroxylation. The administration of 
400 mg 3 times per day permits rapid and effective absorption of delavirdine. 
The recommended dosage for Rescriptor tablets is 400 mg (four 100 mg or two 200 mg 
tablets) 3 times daily. Rescriptor is taken orally and can be consumed with or without food 
and should be used in combination with other antiretroviral therapy. The 100 mg drug can be 
dissolved in water whilst the 200 mg drug cannot be readily dispersed in water, thus it should 
be taken in its intact form. Some drugs when taken together may have interactions which may 
cause a defect in the functionality of the drug and impair the effects that the drug was meant 
to have. Delavirdine has various drug interactions with additional anti-HIV drugs which 
include indinavir, saquinavir and/or amprenavir which may increase with the addition of 
delarvidine, thus the dosage of these drugs should be attuned to compensate the interaction 
(Borin, 1997). 
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2.3 Dendrimers 
 
 
 
 
 
 
Figure 3: Hyperbranched/ tree-like structure of dendrimers 
 
In the recent years polymer chemistry and its relative technologies had traditionally focused 
on linear polymers. These linear polymers rarely contain some branches ranging from short to 
long. It has been found that highly branched macromolecules are different in terms of 
properties to the conventional and well known polymers (Zolezzi, 2002). Due to their highly 
branched structures they have a great impact on various applications. These hyper branched 
molecules are termed dendrimers and were first discovered in the early 1980s by Donald 
Tomalia and co-workers. The term was derived from the word dendron meaning a tree in 
Greek as depicted in Fig.3. Dendrimers are complex macromolecules; they consist of a 
regular highly branched three dimensional structure. Their structure is mainly composed of 3 
components, the core, the end group and branching units that link the two components. 
Dendrimers of lower generations (0, 1, and 2) have highly asymmetric shape and possess 
more open structures as compared to higher generation dendrimers. As the branching 
increases dendrimers tend to assume a globular structure. When they grow and thus reach a 
critical branched state they can no longer grow due to limited space. This phenomenon is 
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known as the starburst effect. The increase in dendrimer generation results in an increase in 
branch density. This is believed to have a major impact on the enhancement of the properties 
of the dendrimers. The globular shape and the presence of internal cavities make dendrimers 
possess unique properties. The most important of these unique properties is the possibility to 
encapsulate guest molecules in the macromolecular interior. 
 
Dendrimers are classified by the generation number which is the number of repeated 
branching of the dendrimers. Dendrimers are produced in iterative reaction steps, in which 
each additional iterative step results in a higher generation dendrimer. Their synthesis is one 
of the examples of controlled hierarchical synthesis using specifically-designed chemical 
reactions. Each successive generation results in double the number of end groups (active 
sites) and with approximately twice as much molecular weight than the previous generation. 
The application of dendrimers in electrochemical biosensors is an emerging area of research. 
The structural homogeneity, biocompatibility, internal porosity, high surface area and ease of 
Functionalization of dendrimers make them very desirable for biosensor applications 
(Klajnert, 2001). 
2.3.1 Types of dendrimers 
 
2.3.1.1 Poly (Propylene imine) dendrimers 
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Figure 4: Structure of PPI dendrimer 
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Poly(Propylene imine) (PPI) dendrimers are generally poly-alkylamines consisting of 
primary amines as the end groups, while the interior of the dendrimer consists of a number of 
tertiary tris-polypropylene amines. The nitrogen atoms serve as the branching points of the 
dendrimer. An alternative name that is occasionally used to describe this class of PPI 
dendrimers is Poly (Propylene amine) (POPAM) (Newkome, 2007). They are also referred to 
as DAB-dendrimers due to the fact that the core structure is usually based on diamino butane. 
PPI dendrimers are available commercially but up to 5 generations. They can be synthesised 
by the divergent method. In the divergent approach the building up of the dendrimer takes 
place in a step wise manner starting from the core and building up the molecule towards the 
periphery using two basic methods (1) coupling of the monomer and (2) the deprotonation or 
transformation of the monomer end group which creates a new reactive surface functionality. 
The synthesis of PPI dendrimer using the divergent methods shows some defects when 
synthesising PPI dendrimers of higher generations (G4-G5). Higher generations are 
characterised by an increase in the number of end groups to be functionalised and the 
increase in the molecular weight of the dendrimer. These characteristics make their synthesis 
very difficult. The application of the divergent method is most successful in the synthesis of 
lower generation dendrimers (G1-G3) (Klajnert, 2003) 
 
2.3.1.2 Metallodendrimers 
 
 
The study of metals coordinated onto dendrimer structures dates back to the year 1992. This 
coordination of metal onto dendrimers generates what is known as metallodendrimers. The 
introduction of metal centers may occur at various branching points within the dendrimers, at 
the core or on the periphery of the dendritic molecule. Metals have played a significant role 
in the synthesis of other, non-dendritic supramolecular structures, and thus their potential 
applicability in the construction of metallodendrimers was evident (Gorman, 1998). The 
incorporation of metals onto dendrimer structures has resulted in materials/molecules with 
enhanced and potentially useful properties. Metals have played an important role in the 
synthesis of other supramolecules other than dendrimers. They have been used in the 
enhancement of the properties of those molecules and thus their potential in their application 
in the construction of the metallodendrimers was evident. Due to their altered properties 
metallodendrimers have various application potential such as their use in the fields of 
catalysis where dendrimers have been employed as multi-centred catalysts. It has been 
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determined that relatively high molecular weight metallodendrimer catalysts could have the 
potential to be easily precipitated from a reaction and recycled. They are also applied in 
sensing where they can influence the microenvironment around a redox centre and thus 
sterically mediate the transfer of electrons (Barner-Kowollik, 2006).  
 
2.4 Polymers 
 
2.4.1 Conducting polymers 
 
Conducting polymers typically contain as the fundamental structural unit, a linear backbone 
of repeating conjugated monomers (Bhakshi, 2004). Conductive polymers were initially 
made in 1930 for the purpose of preventing corona discharge. The potential uses for 
conductively filled polymers have since been multiplied due to their ease of processing, good 
environmental stability and wide range of electrical properties. Over the past 25 years various 
conjugated polymers have been synthesized which exhibit excellent electrical properties 
(Skotheim, 1986). Owing to the delocalization of electrons in a continuously overlapped S-
orbital along the polymer backbone, certain conjugated polymers also possess interesting 
optical and magnetic properties. These unusual optoelectronic properties allow conjugated 
polymers to be used for a large number of applications, including protecting metals from 
corrosion, sensing devices, artificial actuators, all-plastic transistors, non-linear optical 
devices, light-emitting displays, electrocatalysis, rechargeable batteries, membrane 
separation, optoelectronic, chromatography; solar cells (Ahuja, 2007; Malholtra, 2006) and 
most recently they have found great application in electrochemical biosensors. This is 
attributed to properties namely mechanical flexibility, chemical specificities, tunable 
conductivities, high surface areas and easy processing (Ramakrishnan, 1997).  
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2.4.1.1 Polypyrrrole 
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Figure 5: Structure of polypyrrole 
 
 
Polypyrrrole is one of the extensively studied conducting polymers. It is a chemical 
compound that is formed from a number of connected pyrrole ring structures (Fig.5). It is an 
inherently conductive polymer due to interchain hopping of electrons. Polypyrrole is easy to 
prepare by electrochemical techniques and its surface charge characteristics can easily be 
modified by changing the dopant anion that is incorporated during synthesis (Brezoi, 2010). 
Polypyrrole was the first of conducting polymers that shows relative high conductivity. 
Conducting polymer can be synthesised electrochemically or chemically. Polypyrrole can be 
obtained through cationic radical, electrochemically or vapour phase polymerization. Among 
these methods cationic radical is the only way of producing high quantity massive conducting 
polymers and is the most promising in industrial applications. Polypyrrole is mainly 
synthesised electrochemically since it is the simplest method it is a quicker and more 
controllable method in comparison to the chemical method (Zhou, 1999). Pyrrole is 
polymerized through the oxidation of the pyrrole monomer through a pseudo poly 
condensation process. Of all the conducting polymers polypyrrole is the most interesting due 
to the fact that it is easily deposited from aqueous and non-aqueous media, very adherent to 
many types of substrates, and is well-conducting and stable. As a result of its electroactivity, 
high electrical conductivity and stability it is frequently used in commercial applications such 
as sensors, batteries, molecular devices and membranes (Sadki, 2000). 
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2.4.1.2 Electrochemical polymerization of pyrrole 
 
During electrochemical polymerization, the monomer, dissolved in an appropriate solvent 
containing the desired anionic doping salt, is oxidized at the surface of an electrode by 
application of an anodic potential (oxidation). The choice of the solvent and electrolyte is of 
particular importance in electrochemistry since both solvent and electrolyte should be stable 
at the oxidation potential of the monomer and provide an ionically conductive medium. Since 
pyrrole has a relatively low oxidation potential, electropolymerization can be carried out in 
aqueous electrolytes which is not possible for thiophene or benzene (Zhou, 1999). As a result 
of the initial oxidation, the radical cation of the monomer is formed and reacts with other 
monomers present in solution to form oligomeric products and then the polymer. The 
extended conjugation in the polymer results in a lowering of the oxidation potential compared 
to the monomer. Therefore, the synthesis and doping of the polymer are generally done 
simultaneously (Sadki, 2000). The anion is incorporated into the polymer to ensure the 
electrical neutrality of the film and, at the end of the reaction a polymeric film of controllable 
thickness is formed at the anode. The anode can be made of a variety of materials including 
platinum, gold, glassy carbon, and tin or indium–tin oxide (ITO) coated glass. The 
electropolymerization is generally achieved by potentiostatic (constant potential) or 
galvanostatic (constant current) methods. These techniques are easier to describe 
quantitatively and have been therefore commonly utilized to investigate the nucleation 
mechanism and the macroscopic growth. Potentiodynamic techniques such as cyclic 
voltammetry correspond to a repetitive triangular potential waveform applied at the surface of 
the electrode. The latter method has been mainly used to obtain qualitative information about 
the redox processes involved in the early stages of the polymerization reaction, and to 
examine the electrochemical behaviour of the polymer film after electrodeposition. 
 
 
2.4.1.3 Star copolymers 
 
In recent years, focus on electronically conducting polymers has increased in the wake of 
their large number of potential applications emerging in the market, such as in the case of 
light-emitting diodes, electrochemical supercapacitors, sensors, batteries, memory-storage 
devices, electrochromic displays, nonlinear circuit elements and ion gates (Park, 2013). 
Recently the research focus has shifted to the copolymerization to prepare conducting 
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polymers with better properties (properties of both the polymer) and to overcome limitations 
of the variety of new monomers. By applying the proposed electrochemical 
copolymerization, new conducting copolymers have been prepared with pronounced and 
clear advantages in term of enhanced electrochemical property, thermal and environmental 
stability (Gupta, 2014). Star copolymers can be defined as a class of branched 
macromolecules that have a central core to which multiple linear polymer chains are attached. 
The 3D structure with extended conjugated linear polymer chains give star copolymers 
properties that are different from the typical 2D, linear polymers. The combination of star 
copolymer and conducting polymer structures open up an approach to making materials that 
have the favourable properties of both, i.e., improved processability and electrical 
conductivity. Improved process ability results from the spheroidal structure of 
hyperbranched, dendrimeric and starburst polymers (Ottaviani, 1994).  
 
2.5 Biosensors 
 
 
 
 
 
 
Figure 6: Biosensor components  
 
 
The most widely accepted definition of biosensors is it is a self-contained analytical device 
that incorporates a biologically active material in direct contact with an appropriate 
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transduction element for the purpose of detecting (reversibly and selectively) the 
concentration or activity of chemical species in any type of sample (Wang, 1996). A 
biosensor consists of three components, namely, the sensitive biological element, the 
transducer and the signal processor (Fig.6). The sensitive biological element (e.g enzymes, 
nucleic acids, nucleic acids etc) is a biologically derived material or biomimetic component 
that interacts with the analyte under study by recognizing and binding onto it. A typically 
biosensor consists of a bio-recognition component, biotransducer component, and electronic 
system which include a signal amplifier, processor, and display (Pan, 2007). The component 
that is responsible for the recognition of the analyte, called a bioreceptor, utilizes 
biomolecules from organisms or receptors modeled after biological systems to interact with 
the analyte of interest. This interaction is measured by the biotransducer which outputs a 
measurable signal that is proportional to the amount of the target analyte present in the 
sample. The idea behind the design of a biosensor is to facilitate quick, convenient testing at 
the point of concern or care where the sample was procured (Pohanka, 2008). 
The sole mandate of the bioreceptor is to facilitate an interaction with the specific analyte of 
interest that can be measured by the receptor. The analyte of interest is often found amongst a 
matrix of other chemical or biological components. The type of biomolecule employed varies 
depending on the analyte of interest, thus biosensors can be classified based on bioreceptor 
interactions, e.g. Antibody/antigen, enzymes, nucleic acids/DNA (Cornell, 1997). 
 
2.5.1 Electrochemical biosensors 
 
Electrochemical biosensors have been the subject of research for almost five decades. The 
principle of the first enzyme electrode immobilised with glucose oxidase was introduced by 
Leland Clark in the year 1962 at the New York Academy of Sciences Symposium. The most 
typical part of electrochemical biosensors is the presence of a suitable enzyme in the 
biorecognition layer providing electroactive substances for detection by the physico-chemical 
transducer providing the measurable signal. A native enzyme can be used as the 
biorecognition component; in this case the analyte is equal to the enzyme substrate; 
alternatively it may function as its inhibitor. In addition, enzymes can be used as labels bound 
to antibodies, antigens and oligonucleotides with a specific sequence, thus providing affinity-
based sensors. Based on their operating principle, the electrochemical biosensors can employ 
potentiometric, amperometric and impedimetric transducers converting the chemical 
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information into a measurable amperometric signal (Pohanka, 2008). Biosensors are 
categorized according to the basic principles of signal transduction and biorecognition 
elements. According to the transducing elements, biosensors can be classified as 
electrochemical, optical, piezoelectric, and thermal sensors. Electrochemical biosensors are 
also classified as potentiometric, amperometric and conductometric sensors (Kerman, 2004). 
 
2.5.1.1 Amperometric biosensors 
 
Amperometric biosensors are quite sensitive and more suited for mass production than the 
potentiometric ones. Amperometric biosensors can work in two- or three-electrode 
configurations. The former case consists of reference and working (containing immobilized 
biorecognition component) electrodes. The main disadvantage of the two-electrode 
configuration is limited control of the potential on the working electrode surface with higher 
currents, and because of this, the linear range could be shortened. To solve this problem, a 
third auxiliary electrode is employed. Now voltage is applied between the reference and the 
working electrodes, and current flows between the working and the auxiliary electrodes. The 
working electrode of the amperometric biosensor is usually either a noble metal or a screen-
printed layer covered by the biorecognition component (Liepold, 2005). Amperometric 
biosensors are based on the monitoring of the electron transfer processes that take place. The 
signal of these biosensors is generated through the electron exchange that occurs between the 
biological system and the electrode. On amperometric biosensors the analyte undergoes a 
redox reaction followed by the measurement of the current in an electrochemical cell. The 
analyte, or the species involved with it via a (bio) chemical reaction, changes its oxidation 
state at one electrode. The electron flux is then monitored and is proportional to the amount 
of the species electrochemically transformed at the electrode (Belluzo, 2008). The 
amperometric biosensors are often used on a large scale for analytes such as glucose, lactate 
(Ohnuki et al. 2007), and sialic acid (Marzouk, 2007).  
 
 
2.5.1.2 Potentiometric biosensors 
 
Potentiometric biosensors are based on ion-selective electrodes (ISE) and ion-sensitive field 
effect transistors (ISFET). The primary outputting signal is possibly due to ions accumulated 
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at the ion-selective membrane interface (Belluzo, 2008). Current flowing through the 
electrode is equal to or near zero. The electrode follows the presence of the monitored ion 
resulting from the enzyme reaction (Kauffmann, 1991). Nowadays, semi conductor based 
physico-chemical transducers are more common. ISFETs and light addressable 
potentiometric sensor (LAPS) based systems especially are convenient for biosensor 
construction. The ISFET principle (Yuqing, 2003) is based on a local potential generated by 
surface ions from a solution. The LAPS principle (Yoshinobu, 2005) is based on 
semiconductor activation by a light-emitting diode (LED). The sensor is made from an n-type 
silicon typically coated with 30 nm of silicon oxide, 100 nm of silicon nitride, and indium-tin 
oxide. The LAPS measures a voltage change as a function of medium pH in the LED 
activated zone. This opens the way for multiposition sensing and construction of an array of 
biorecognition zones. A potentiometric biosensor with a molecularly imprinted polymer 
constructed for the herbicide atrazine assay allows detecting from 3×10-5 to 1×10-3 M 
(D´Agostino, 2006); molecularly imprinted polymer was also used for tracking the level of 
neurotransmitter serotonin (Kitade, 2004). Potentiometry is rarely used in biosensing methods 
especially with enzymes immobilized on electrodeposited conducting polymers in which pH 
sensitivity of the conducting polymer is used (Mascini, 2002).  
 
2.5.1.3 Impedimetric biosensors 
 
Such devices follow either impedance (Z) or its components resistance (R) and capacitance 
(C); inductance typically has only a minimal influence in a typical electrochemical setup.  
The inverse value of resistance is called conductance and for this reason some investigators 
name such systems as conductometric. Impedance biosensors include two electrodes with 
applied alternating voltage; amplitudes from a few to 100 mV are used. The impedance 
biosensor is commonly a functional part of the Wheatstone bridge. These systems are 
considered for the assay of urea when urease is used as a biorecognition component. 
Alternatively, impedance biosensors have been successfully used for microorganism growth 
monitoring due to the production of conductive metabolites (Silley, 1996). The main 
disadvantage of impedence biosensors is that they give false positive results due to 
electrolytes from the samples. Impedimetric biosensors are less frequent compared to 
potentiometric and amperometric biosensors; nevertheless, there have been some promising 
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approaches. Hybridization of DNA fragments previously amplified by a polymerase chain 
reaction has been monitored by an impedance assay (Belluzo, 2008). 
 
2.6 Enzyme 
 
Enzymes are proteins that possess high catalytic activity and selectivity towards substrates. 
They have been used for decades to assay the concentration of diverse analytes (Pohanka, 
2008). Their commercial availability at high purity levels makes them very attractive for 
mass production of enzyme sensors. Their main limitations are that pH, ionic strength, 
chemical inhibitors, and temperature affect their activity. Most enzymes lose their activity 
when exposed to temperatures above 60.8
o
C. Drug metabolizing enzymes are a group of 
different proteins; they are responsible for the metabolism of a vast different number of 
xenobiotic compounds which includes drugs, environmental pollutants and endogenous 
compounds such as steroids and prostaglandins (Zanger, 2013).  
 
 
2.6.1 Cytochrome P450 
 
Cytochrome P450 (CYP) is from a large family of heme enzymes that catalyze a diversity of 
chemical reactions such as epoxidation, hydroxylation and heteroatom oxidation. The hepatic 
CYP are a multigene family of enzymes that play a vital role in the metabolism of many 
drugs and xenobiotics with each cytochrome isozyme responding differently to exogenous 
chemicals in terms of its induction and inhibition. Their catalytic ability has attracted a lot of 
interest of enzyme engineers since the 1970’s (Bistolas, 2005). Only about a dozen enzymes 
belonging to the 1, 2, and 3 CYP-families are responsible for the metabolism of the majority 
of drugs and other xenobiotics. Despite the broad and overlapping substrate specificities of 
these enzymes, many drugs are metabolized at clinically relevant concentrations by one or 
few enzymes only. The CYP1 familyconsists of three functional genes in two subfamilies. 
The highly conserved CYP1A1 and CYP1A2 genes consist of seven exons and six introns 
and are located on chromosome 15q24.1, whereas CYP1B1 consists of only three exons 
located on chromosome 2p22.2 (Zanger, 2013). Catalytic activities of the CYP1 enzymes are 
overlapping and include hydroxylations and other oxidative transformations of many 
polycyclic aromatic hydrocarbons and other aromatic substances. Whereas CYP1A1 prefers 
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planar aromatic hydrocarbons, CYP1A2 shows a preference for aromatic amines and 
heterocyclic compounds. Due to its relatively high expression in liver, CYP1A2 plays a 
significant role in the metabolism of several clinically important drugs. These include 
analgesics and antipyretics (acetaminophen, phenacetin, lidocaine), antipsychotics, 
antidepressants, anti-inflammatory drugs, cardiovascular drugs (propranolol, guanabenz, 
triamterene), the cholinesterase inhibitor tacrine used for the treatment of Alzheimer's 
disease, the muscle relaxant tizanidine. The CYP2 family contains 16 full-length genes, 
which all have 9 exons and 8 introns. Several of the most important hepatic drug 
metabolizing CYPs but also extrahepatic enzymes and several “orphan” P450s with still 
unclear function are found in this family. The genes are spread over different chromosomes 
and organized in multi-gene clusters containing one or several subfamilies. Most 
pharmacologically important CYP2 genes are highly polymorphic, in particular CYP2A6, 
CYP2B6, CYP2C9, CYP2C19, and CYP2D6. 
 
The human CYP3 family consists only of one subfamily, CYP3A,which is located on 
chromosome 7q22.1. In humans, there are four CYP3A genes namely CYP3A4, CYP3A5, 
CYP3A7, and CYP3A43. CYP3A4 is expressed at high levels in adult liver and small 
intestines. The CYP3A drug-metabolizing enzymes facilitate the metabolism and elimination 
of a wide range of structurally different xenobiotics and of 50% of all therapeutic drugs used 
in the clinics (Ingelman-Sundberg, 2007). CYP3A4 is the major expressed P450 in intestinal 
enterocytes, with levels uncorrelated to those of liver, and contributes substantially to the 
first-pass metabolism of orally administered drugs (Zanger, 2013). In this study CYP3A4 
enzyme was used as a bio-component in developed electrochemical sensor for delavirdine 
drug. 
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2.6.2 Mechanism of CYP450 Enzyme complex 
 
 
 
 
 
 
 
Figure 7: Catalytic cycle of CYP 
 
The P450 catalytic cycle (Fig.7) shows the steps involved when a substrate binds to the 
enzyme in the normal state of a P450 with the iron in its ferric [Fe
3+
] state. When the 
substrate binds to the enzyme, the enzyme is reduced to the ferrous [Fe
2+
] state by the 
addition of an electron from NADPH cytochrome P450 reductase. The bound substrate 
facilitates this process. Molecular oxygen binds and forms a Fe
2+
OOH complex with the 
addition of a proton and a second donation of an electron from either NADPH cytochrome 
P450 reductase or cytochrome b5. A second proton cleaves the Fe2+OOH complex to form 
water. An unstable [FeO]
3+
 complex donates its oxygen to the substrate. The oxidised 
substrate is released and the enzyme returns to its initial state. The active site of cytochrome 
P450 contains a heme iron center. The iron is tethered to the P450 protein via a thiolate 
ligand derived from acysteine residue. This cysteine and several flanking residues are highly 
conserved in known CYPs enzyme complex 
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3.0 Summary  
This chapter describes the procedures for the synthesis of G2PPI-2Py and (Cu(G2PPI)-co-
PPy using appropriate reagents. This chapter contains the immobilization procedure used to 
attach the enzyme for the development of biosensor. Also included in the chapter are the 
characterization procedures for the biosensors as well as other materials used towards the 
fabrication of the biosensors using various techniques; spectroscopic (FTIR) and (EDS), 
microscopic (HRSEM, HRTEM) and electrochemical Cyclic voltammetry (CV). 
 
3.1 Reagents 
 
Pyrrole-2-carboxy aldehyde (98%), dichloromethane (98%), methanol (›99.9%), copper 
acetate monohydrate (99.99%) and generation 2 poly(propylene imine) dendrimer were 
purchased from Sigma Aldrich while ethanol 96.4% purchased from Kimix were used for the 
preparation of copper metalodendrimer. Electropolymerization was achieved by the use of 
reagent grades pyrrole (98%) and lithium per chlorate (99.9%) were purchased from Sigma 
Aldrich. The reaction medium, pH 7.4, 0.1 M phosphate buffer was prepared from sodium 
phosphate dibasic dihydrate (HNa2O4P.2H2O) (≥99.5%) and sodium phosphate monobasic 
dihydrate (H2NaO4P.2H2O) (≥99%) that were purchase from Sigma Aldrich. Immobilisation 
reagents such as grade I 25% glutaraldehyde was purchased from Sigma Aldrich while bovin 
serum albumin (BSA) was purchased from Fluka. Cytochrome P450-3A4 (CYP3A4) human 
expressed in Saccharomyces cerevisiae was purchased from Sigma Aldrich. The 
nanobiosensor substrate deavirdine mesylate was purchased from Sigma alridch. Alumina 
micro polishing pads were obtained from Buehler LL, USA. De-ionized ultra-purified water 
used throughout these experiments was prepared with a Milli-Q water purification system. 
 
3.2 Intsrumentation 
 
All electrochemical measurements were done using BASi epsilon from Bio Analytical 
Systems (BAS), Lafayette, USA.  
All cyclic voltammograms were recorded with computer interfaced to BASi epsilon using a 
10 mL electrochemical cell with a three electrodes set up. The electrodes used in the study 
were (1) Platinum working electrode (A = 0.0201 cm
2
) from BAS, (2) platinum wire from 
 
 
 
 
28 
 
Sigma Aldrich acted as counter electrode and (3) Ag/AgCl from BAS kept in (3 M NaCl) was 
the reference electrode and alumina micro polishing pads were obtained from Buehler, LL, 
USA and were used for polishing the platinum working electrode before modification. 
HRTEM images were taken using Tecnai G2 F20X-Twin MAT 200kV Field Emission 
Transmission Microscopy from FEI (Eindhoven, Netherlands). All FTIR spectra were 
recorded on spectrum 100 FTIR spectrometer (PerkinElmer, USA) in a region of 400 to 4000 
cm
-1
. All samples were dried using Buchi rotarvapor and buchi waterbath from labotech at 
60
0
C. 
3.2.1 Spectroscopic techniques 
3.2.1.1 Fourier transform infra-red spectroscopy (FTIR) 
 
Infrared spectroscopy is one of the most important analytical techniques available to today’s 
scientists. Infra-red spectroscopy is the study of the interaction and relationship between 
matter and electromagnetic fields in the infra red region. It is a powerful tool that provides 
information about the chemical composition of a sample. One of the great advantages of 
infrared spectroscopy is that virtually any sample in virtually any state may be studied. 
Liquids, solutions, pastes, powders, films, fibres, gases and surfaces can all be examined with 
a judicious choice of sampling technique. As a consequence of the improved instrumentation, 
a variety of new sensitive techniques have now been developed in order to examine formerly 
intractable samples (Stuart, 2004). In the study it was used for the determination of the 
chemical compositions of (Cu(G2PPI-2Py) metallodendrimer and G2PPI-2Py and to identify 
the types of interactions present in the complexes.  
 
3.2.1.2 Energy dispersive spectroscopy (EDS) 
 
Energy Dispersive Spectroscopy (EDS) makes use of the X-ray spectrum emitted by a solid 
sample bombarded with a focused beam of electrons to obtain a localized chemical analysis. 
All elements from atomic number 4 (Be) to 92 (U) can be detected in principle, though not all 
instruments are equipped for 'light' elements (Z < 10). Qualitative analysis involves the 
identification of the lines in the spectrum and is fairly straightforward owing to the simplicity 
of X-ray spectra. Quantitative analysis (determination of the concentrations of the elements 
present) entails measuring line intensities for each element in the sample and for the same 
elements in calibration Standards of known composition (Ramamurthy, 2009).  In this study 
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EDS was used for the determination of the presence of the copper element in G2PPI-2Py and 
(Cu(G2PPI-2Py) respectively. It was determined that copper was present in the (Cu(G2PPI-
2Py) but not in G2PPI-2Py, signifying successful incorporation of copper nanoparticles. 
 
3.2.2 Microscopic techniques 
 
3.2.2.1 High resolution transmission electron microscopy (HRTEM) 
 
High resolution Transmission electron microscopy uses a series of electromagnetic lenses for 
the manipulation of an electron beam generated at a high potential in an electrically heated 
filament. In HRTEM the image and corresponding diffraction pattern from the same part of 
the sample, the concentration of the elements in the sample as well as the mapping of the 
elements in the same region of the sample can be obtained through the analysis of the image 
and the corresponding diffraction useful information can be obtained about the grain size, 
precipitates and their orientation on the matrix and on the appearance of the superstructure 
(Tonejc, 1999). In this study HRTEM was used to determine the particle size and shape of the 
copper nanoparticles that was incorporated into the dendrimer which were determined to be 
12-17 nm and spherical in shape. 
3.2.2.2 High resolution scanning electron microscopy (HRSEM) 
 
High resolution scanning electron microscopy is a microscopic technique that uses the 
interaction between an electron beam and the atoms of the targeted sample to generate an 
image through the emission of different signals (Sun, 2007). The general principle essential 
to electron microscopy techniques is the interaction between an electronic beam and the 
atoms of a target sample. In HRSEM, a high-energy, very thin electron beam is finely 
focused over a sample and swept in a raster across the surface. The electron beam and sample 
interactions cause the emission of different signals, which are collected by specific detectors 
and converted into an image of the sampled area. The signals generated include secondary 
electrons. The signals of greatest interest for surface topography are secondary and 
backscattered electrons. The characteristic X-rays, emitted as a result of electron 
bombardment, are element specific and permit both qualitative and quantitative elemental 
analysis in electron probe microanalysis (Marassi, 2009). In the study it was used for the 
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determination of the surface morphologies of G2PPI-2Py and (Cu(G2PPI-2Py) 
metallodendrimer and to determine whether there was any change in the morphology after 
introduction of copper nano particles. Where the SEM of G2PPI-2Py showed a rough surface 
and that of (Cu(G2PPI-2Py) after copper incorporation. 
 
3.2.3 Electrochemical techniques 
 
3.2.3.1 Cyclic Voltammetry (CV) 
 
Cyclic voltammetry is the most widely used technique for acquiring qualitative information 
about electrochemical reactions. Is a technique that is mostly used to acquire qualitative 
information about electrochemical reactions that occur. It offers a rapid location of redox 
potentials of the electroactive species (Andrienko, 2008).  This technique can be used to get 
valuable kinetic information of electrode reaction. Electrode reaction usually involves 
electron transfer reaction which is influenced by electrode potential. Voltammetry is used to 
investigate electrode mechanism. Advantages of this technique include its broad accessibility 
due to its low cost and the accessibility to extensive theory for electrochemist as well as other 
field of specialists. However this technique has some drawbacks which include the difficulty 
to determine the mechanism of the second of two or more closely spaced charge transfer 
reactions (Nicholson, 1965). In this study CV was used to determine the electrochemical 
activity of (Cu(G2PPI)-co-PPy) and G2PPI-2Py whereby there was an observed increase in 
current with an increase in applied potential and was used for the testing of the biosensor and 
determination of the analyte of interest. 
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3.3 Methodology 
 
3.3.1 Synthesis of 2-Pyrrole functionalized Poly(propylene imine) dendrimer (PPI-2Py) 
 
The synthesis of G2PPI-2Py was carried out by, first, a condensation reaction of PPI with 
Pyrrole-2- carboxy aldehyde. A reaction mixture of PPI generation 2 (1 g, 3.15 mmol) and 
pyrrole-2- aldehyde (1.2 g, 12.625 mmol) in 50 ml dry methanol the mixture was 
magnetically stirred under a positive pressure of nitrogen gas for 2 d in a 100 ml three-necked 
round bottom flask. Methanol was removed by rotary evaporation, the residual oil was 
dissolved in 50 ml dichloromethane (DCM), and the organic phase was then washed with 
water (6 × 50 ml) to remove unreacted monomer. The DCM was removed by rotary 
evaporation and the desired product was an orange oil (Baleg, 2011). 
 
3.3.2 Synthesis of generation 2 copper metallodendrimer 
 
Cu (OAC)2. H2O (1mmol) and G2PPI-2Py (0.25mmol) were mixed in 20 ml methanol. The 
mixture was refluxed for 4h yielding a green precipitate. The mixture was cooled to 0
o
C and 
the mixture was filtered under vacuum and dried in the oven at 300
o
C. The product was 
recrystallized from 1:2 dichloromethane/ethanol mixture at -4
o
C for 72 h (Mapolie, 2013). 
 
3.4 Pre-treatment of working electrode 
 
A platinum working electrode was polished with 1, 0.5 and 0.03 μm alumina slurries in 
polishing pads, minimum of 5 min on each pad, after polishing, the electrode was ultra-
sonicated for 15 min, with distilled water and absolute ethanol respectively to remove any 
possibly adsorbed alumina crystals on the electrode surface and rinsed carefully with distilled 
water. The above procedure resulted into a clean platinum working electrode.  
 
3.4.1 Electrochemical polymerization of pyrrole on Pt electrode 
 
Electrochemical polymerization of Py on Pt electrode surfaces coated with G2PPI-2Py was 
carried out in an electrochemical cell containing 5 mL of 0.1 M aqueous lithium perchlorate 
solution as support electrolyte and 75 μL of Py monomer. Electrochemical polymerization 
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was achieved by CV (+800 mV to -800 mV), performed at a scan rate of 50 mV/s, for 30 
cycles. Before applying the potential to the above polymerization solution, the solution was 
degassed by bubbling argon gas through for 15 min, and then maintaining it oxygen-free by 
keeping a blanket of argon above the solution. Oxygen was removed to ensure that it didnot 
interfere with the electronic processes that takes place on the surface of the electrode. It is 
during this electropolymerization process that PPy is electrodeposited on the surface of the 
coated electrode. The modified electrode (PPy/PtE) was then removed from the solution and 
rinsed with water to remove any traces of monomer. 
 
3.4.2 Electrochemical polymerization of Pyrrole on Pt electrode surface coated with 
G2Cu-PPI-2Py 
 
3 μL G2Cu-PPI-2Py was drop-coated onto platinum working electrode and dried for 4 h. 
Electrochemical polymerization of Py on Pt electrode surfaces coated with G2PPI-2Py was 
carried out in an electrochemical cell containing 5 mL of 0.1 M aqueous lithium perchlorate 
solution as support electrolyte and 75μL of Py monomer. Electrochemical polymerization 
was achieved by CV (+800 mV to -800 mV), performed at a scan rate of 50 mV/s, for 30 
cycles. Before applying the potential to the above polymerization solution, the solution was 
degassed by bubbling argon gas through for 15 min, and then maintaining it oxygen-free by 
keeping a blanket of argon above the solution. It is during this electropolymerization process 
that PPy is electrodeposited on the surface of the coated electrode. The modified electrode 
(Cu(G2PPI)-co-PPy) was then removed from the solution and rinsed with water to remove 
any traces of monomer.  
  
 
3.4.3 Fabrication of biosensors 
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Figure 8: Schematic representation for development of CYP3A4/(Cu(G2PPI)-co-PPy)/Pt 
/Au biosensor 
48 h 
Methanol 
 
N
N N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
Cu Cu
N
N
N
N Cu
Cu
 
Cu(OAC.H2O) 
Electropolymerization of 
Py  
onto Pt electrode 
N N
N
N
N
N
N
N
N
N
N
N
N
N
NH
N
H
N
H
N
H
N
H
N
HN
H
N
H
 
N N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
H
N
H
N
H
N
H
N
H
NH
H
N
H
N
H
N
H
N
H
N
H
NH
H
N
H
N
H
N
H
N
H
N
H
N
H
N
H
N
H
N
H
N
H
N
H
N
H
Cu
Cu
N
N
N
N
Cu
Cu
n
n
n
n
n
n
n
n
 
N N
N
N
N
N
NH2
NH2
NH2
NH2
NH2
NH2
NH2
NH2
G2-PPI dendrimer
 
N
H
O
 
N N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
N
H
N
H
N
H
N
H
N
H
NH
H
N
H
N
H
N
H
N
H
N
H
NH
H
N
H
N
H
N
H
N
H
N
H
N
H
N
H
N
H
N
H
N
H
N
H
N
H
Cu
Cu
N
N
N
N
Cu
Cu
n
n
n
n
n
n
n
n
 
 
(Cu(G2PPI)-co-PPy)/Pt 
CYP 3A4/(Cu(G2PPI)-co-PPy)/Pt 
Attachment of CYP3A4 onto 
(Cu(G2PPI)-co-PPy)/Pt 
  
 
 
 
 
34 
 
3.4.3.1 Fabrication of CYP3A4 biosensor: CYP/Pt 
 
3 μL of a 1M CYP enzyme solution, containing 2.0 mg BSA and CYP3A4 was carefully 
drop-coated onto clean Pt electrode. 2 μL 2.5% glutaraldehyde solution was drop-coated onto 
platinum working electrode containing CYP3A4 and BSA solution.  The CYP3A4 modified 
electrode was covered in a tight fitting lid for first 10 min to allow the formation of a uniform 
layer, the lid was removed and the enzyme was allowed to dry for 4 h at 4
o
C. The resulting 
electrode was rinsed with 0.1 M PBS pH 7.4 to remove any physically adsorbed enzyme. The 
CYP3A4-based biosensor was denoted CYP3A4/Pt and was kept at 4
o
C in 0.1M PBS pH 7.4 
when not in use. 
 
3.4.3.2 Fabrication of CYP 3A4 biosensor: (Cu(G2PPI)-co-PPy)/BSA/Glu/Pt 
 
CYP3A4 was immobilized on the (Cu(G2PPI)-co-PPy)/Pt by drop-coating. 3μL of a 1M 
enzyme solution, containing 2.0 mg BSA and CYP3A4 was carefully drop-coated onto the 
Cu-PPI-PPy modified Pt electrode. 2 μL 2.5% glutaraldehyde solution was drop-coated onto 
modified electrode. The enzyme-modified electrode was then covered with a tight fitting lid 
for the first 10 min to form a uniform layer, after which, the lid was removed and the enzyme 
layer was slightly dried for another 40 min, but still retaining wet camera (wet camera 
consisting of CYP3A4, glutaraldehyde and BSA) after which the prepared biosensor was 
immediately placed at 4
o
C for at least 1h. The CYP3A4-based biosensor was denoted CYP 
3A4/ (Cu(G2PPI)-co-PPy)/Pt. 
3.5 Preparation of Delavirdine stock  
 
5 mg of powder delavirdine drug was placed in a 100 ml volumetric flask which was filled up 
to the mark with 0.1 M sodium phosphate buffer solution, pH 7.4. Un-dissolved components 
were removed by filtering the formed suspension through a Whatman polytetrafluoroethylene 
35 syringe filter (pore size 0.3 μm) into a clean storage bottle and the concentration of 
prepared delavirdine was found to be 100 μM. The solution was used as stock delavirdine 
solution from which all the other working solutions were prepared using appropriate dilutions 
with 0.1 M sodium phosphate buffer pH 7.4. 
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Chapter 4 
Results and discussion 
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4.0 Summary  
 
This chapter deals with the characterisation of G2PPI-2Py and (Cu(G2PPI-2Py) using FTIR, 
HRSEM, HRTEM and EDS. Also included in this chapter is the electrochemical investigation 
and properties of PPy and Cu-PPI-PPy using CV.  
 
4.1 Spectroscopic characterisation of G2 PPI-2Py and (Cu(G2PPI-2Py) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: FTIR spectra of (Cu(G2PPI-2Py)and G2PPI-2Py. 
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Table 1: Bonds and their respective frequencies in the structure of the G2PPI-2Py and 
(Cu(G2PPI-2Py) metallodendrimer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.1 Fourier transformed infrared spectroscopy (FTIR) 
 
Fourier transform infrared spectroscopy was used to determine the structure of the G2PPI-
2Py dendrimer and the (Cu(G2PPI-2Py) metallodendrimer. Fig.9 shows the FTIR spectra of 
(Cu(G2PPI-2Py) and G2PPI-2Py while  table 1 shows the types of bonds that are present in 
the molecules as well as their respective wave numbers. The FTIR spectra shows 
characteristic (NH), ν(C=C), ν(C-N) aliphatic bond bands at, 3413 cm-1,1642 cm-1,1306 cm-1 
for  the pyrrole ring for both the (Cu(G2PPI-2Py) and G2PPI-2Py complexes.  The broad 
band at 3413 cm
-1 
represents the N-H stretching vibrations in the pyrrole ring while the C-N 
bond of the dendrimer moiety is found at 1250 cm
-1
. The spectra of G2PPI-2Py shows out-of-
plane bending of the C–H bond located at the α position in the Py ring appearing at 729 cm-1 
while the sharp band at 1634 cm
-1
 is assigned to the N=C bond stretching vibration present in 
the dendrimer moiety. The appearance of these two characteristic peaks confirms the 
functionalization of the amine groups of PPI by 2-Py. (Cu(G2PPI-2Py) compared to G2PPI-
2Py was found to have an increase in the intensities of all its peaks. This phenomenon can be 
attributed to the codative bonding that exists between the dendrimer moiety and the metal 
Frequency, 
 cm
–1
 
Bond Type 
3400-3250 N-H 
1680-1640 -C=C 
1335-1250 C-N Stretch aromatic 
1600–1585 C-C Stretch 
1250-1220 C-N Stretch aliphatic 
2800-3000 CH Stretch   
1640-1690 C=N 
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which can sometimes be described as an artificial bond. This signifies that there was no 
breakage of existing bonds or formation of new bonds after addition of the copper metal. This 
phenomenon is also observed on the spectra of the (Cu(G2PPI-2Py) metallodendrimer where 
no evidence of new peaks was indicated but showing only those of covalent bonding between 
2-Py and the dendrimer moiety. 
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4.2 Microscopic characterisation of G2PPI-2Py and (Cu(G2PPI-2Py) 
4.2.1 High resolution scanning electron microscopy (HRSEM) 
 
 
 
 
Figure 10: The High Resolution Scanning Electron Microscope (HRSEM) images of 
G2PPI-2Py (A) and (Cu(G2PPI-2Py) (B). 
A 
B 
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The surfaces of G2PPI-2Py Fig.10 (A) and (Cu(G2PPI-2Py) Fig.10 (B) were studied using 
high resolution scanning electron microscopy. The morphology of the G2PPI-2Py in Fig.10 
(A) shows a rough surface and a tightly packed structure which can be attributed to the sticky 
nature of the dendrimer; whilst that of the (Cu(G2PPI-2Py) shows that there was a change in 
the surface morphology of the dendrimer moeity after it was functionalized with the copper 
metal. The surface became smoother and was less densley packed than the surface of the 
dendrimer moeity. Observed on the suface are  cavities which are beneficial for entrapment 
or the adsorption of enzymes. These cavities allow for much more enhanced stability of the 
enzyme onto the electrode thus act as good support material for their application in biosensor 
development.  
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4.2.2 High resolution transmission Electron Microscope (HRTEM) 
 
 
  
 
 
Figure 11: The High ResolutionTransmission Electron Microscope (HRTEM) images of 
G2PPI-2Py (A) and (Cu(G2PPI-2Py) (B)  
A 
B 
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HRTEM determines the shape and size of nanoparticles. In this study it was used to 
determine the size and shape of copper nanoparticles present in the (Cu(G2PPI-2Py) 
complex. Fig.11 (A) and (B) represent the internal structures of the G2PPI-2Py and 
(Cu(G2PPI-2Py) components respectively. The structure of G2PPI-2Py shows the spherical 
shape of the dendrimer which is the typical shape of dendrimers. The observed copper 
nanoparticles in Fig.11 (B) are agglomerated due to their small size and their high surface 
area. The particles are seen to have formed adjacent bond with other nanoparticles due to 
their smaller size, higher relative surface area, and higher relative numbers of surface atoms. 
This phenomenon resulted in their atoms having unsaturated coordinations  further resulting 
in the atom having vacant coordination sites thus forming more bonds by bonding with other 
atoms. The particles were found to be in the range of 15-20 nm with an average particle size 
of 17 nm. 
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4.2.3 Energy dispersive spectroscopy (EDS)  
 
 
 
 
 
 
 
Figure 12: The Energy Dispersive X-ray radiation (EDX) Spectrum of the (Cu(G2PPI-
2Py) (A) and (B) G2PPI-2Py. 
 
Energy Dispersive X-ray radiation (EDX) was used to determine which elements were 
present in G2PPI-2Py (Fig.12 (B)) and (Cu(G2PPI-2Py) (Fig.12(A)) metallodendrimer. The 
B 
A 
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EDX spectra of G2PPI-2Py indicates that the material showed the presence of nitrogen and 
carbon atoms. On Fig. 12(A) it was observed that there was presence of copper which was the 
main metal of interest as its presence means there was successful functionalization of the 
copper into the G2PPI-2Py dendrimer. The presence of nitrogen in this spectrum is in line 
with the structure of the dendrimer which consists of nitrogen atoms. The oxygen is due to 
the unreacted oxygen from the copper acetate which was used as the source of the copper 
metal thus; it can be regarded as an impurity. The EDS of the dendrimer indicated the 
elements carbon, nitrogen and chlorine with chlorine being an impurity that was present in 
the compound. Carbon and the nitrogen were expected as the structure of G2PPI-2Py 
contains nitrogen and carbon atoms only. 
4.3 Electrochemical polymerization characterisation of PPy and (Cu(G2PPI)-co-PPy) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Electrochemical polymerization of Py onto Pt electrode in 0.1 M lithium 
perchlorate (+800 mV) to (-800 mV) at scan rate 50 mV/s. 
 
Fig.13 shows cyclic voltammograms for the electrochemical polymerization (+800 mV to -
800mV) of pyrrole on a Pt electrode performed at a scan rate of 50 mV/s for 30 cycles in 
lithium perchlorate. At the initial oxidation step, the radical cation of the monomer is formed 
and reacts with other monomers present in solution to form oligomeric products and then the 
polymer. It is observed that there is an increase in current with increasing number of cycles, 
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implying deposition of an electroactive material on the surface of the electrode. 
Polymerisation of the monomer shows a reduction peak at -305 mV which is due to the 
monomer being deposited on the electrode surface. While the peak at +65 mV is due to the 
formation of polymer chains. There is an observable shift in the anodic potential towards the 
negative potential with an increase in number of cycles. This is due to the extended 
conjugation in the polymer which results in a lowering of the oxidation potential compared to 
the monomer. The polymer is therefore more easily oxidized at the applied potential which is 
the oxidation potential of the monomer. Therefore, the synthesis and doping of the polymer 
are generally done simultaneously. The anion is incorporated into the polymer to ensure the 
electrical neutrality of the film and at the end of the reaction, a polymeric film of controllable 
thickness is formed at the anode. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Cyclic voltammogram of PPy/Pt electrode in 0.1 M pH 7.4 phosphate buffer 
at scan rates (10 mV/s to 100 mV/s). 
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Fig.14 represents the cyclic voltammogram of Py/Pt in 0.1 M pH 7.4 phosphate buffer at the 
potential window of (+800 mV to -800 mV). There are two peaks that are observable in the 
voltammograms A and A
l
 where the anodic peak (A) at +550 mV is due to the oxidation of 
the pyrrole while the cathodic peak (A
l
) at +495 mV is due to the deposited pyrrole onto the 
electrode surface. There is a shift of the anodic potential towards more positive potential with 
an increase in scan rate from +550 to +620 mV showing a more readily oxidised species. 
There is an observable linear increase in the anodic peak current with an increase in scan rate 
(as shown in Fig.14) which indicates the occurrence of the electrochemistry of surface 
confined species. There is no shift in the cathodic peak current indicative of a surface bound 
species. ΔEp [Ep,a – Ep,c ] was calculated for the polymer film grown at different scan rates 
resulted in a value of ΔEp greater than 65 mV.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: Randle Sevčik plot of PPy in 0.1M phosphate buffer PH 7.4 at different scan 
rates for the determination of the diffusion co-efficient. 
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Fig.15 shows the linear dependency of the current on the scan rate of the redox couple A/A
l  
shown in Fig. 14.  This is indicative of a thin surface bound conducting electro-active 
polymer film undergoing a rapid reversible electron transfer reaction along the polymer 
backbone possibly through the pyrrole ring units making up the chain of the polymer. The 
surface concentration of the polymer was estimated to be 1.00x 10
-4 
mol/cm
-3 
(0.6 ± 0.1) 
using the Brown-Anson method illustrated as follows: 
 
4RT
Aν*ΓFn
I
(PPy)
22
p          (1) 
where n represents the number of electrons involved in the reaction, F is the Faradays 
constant (96,584 C/mol), Г*(PPy) is the surface concentration of the PPy film (mol/cm
2
), ν is 
the scan rate (mV/s), A is the electrode area of the electrode (0.0201 cm
2
), R is the universal 
gas constant (8.314 J/(mol K)) and T is the temperature of the system (298 K). The 
magnitude of the peak currents was seen to increase upon increment of the scan rate 
suggesting that the peak currents are diffusion controlled. 
 
Randle Sevčik Plot given, for analysis of diffusion controlled reactions: 
 
              
  
  
   
    
      
                             (2) 
 
Where Ip = (Peak Current in μA), n = 1 (number of electrons), F = 96485 C/mol (Faradays 
Constant), A = 0.0201 cm
2
 (area of the electrode), C0 * = 1.00x 10
-4 
 mol/dm
2
(Concentration 
of bulk substrate concentration), R = 8.314 J mol/ K (Gas Constant), T = 298.15 K (absolute 
Temperature) and ν = (Scan Rate in V/s) and D0 (difusion co-efficient). 
 Do is the electron charge transport coefficient sometimes also known as the rate of electron 
charge propagation along the polymer chain. Fig.14 indicates an oxidation reaction that was 
occurring at Epa which was seen to be diffusion controlled with a correlation co-efficient of 
R
2
 = 0.9424 and a diffusion co-efficient of Do = 1.243 x 10
-5
 cm
2
/s; indicating a faster 
electron transfer kinetics within the diffusion layer. The reduction current peak (Epc) had a 
correlation co-efficient of R
2 
= 0.9634 linearity in the Randle Sevčik plots obvious case was 
that this reductive reaction that was occurring at that potential was diffusion controlled, and a 
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diffusion co-efficient of 5.528 x 10
-5
 cm
2
/s indicating a slower electron transfer compared to 
the anodic electron transfer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Electropolymerization of Py onto Cu-PPI-2py/Pt electrode in 0.1 M lithium 
perchlorate at 50mV/s. 
 
Fig.16 shows the cyclic voltammograms for the electrochemical polymerization (at the 
potential window of +800 mV to -800mV) of pyrrole on Pt electrode performed at a scan rate 
of 50 mV/s for 30 cycles in lithium perchlorate. The electrochemical polymerisation of 
pyrrole is characterised by an increase in current with an increase in the number of cycles. 
There is observed separation between the anodic and cathodic scans which are attributed to  
the good conductivity of the star copolymer doped with copper nanoparticles. The broadness 
of the cathodic and anodic peaks is due to the slow movement of the electrons during the 
polymerisation process. The cathodic peak at -305 mV is due to the dendrimer attached on 
the surface of the electrode and peak at +106 mV can be attributed to the deposition of 
pyrrole onto already existing copper metallodendrimer on the surface of the electrode, while 
the peak at +100 mV in the anodic scan can be attributed to the formation of the copolymer  
chain. 
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Figure 17: Cyclic voltammogram of (Cu(G2PPI)-co-PPy)/Pt in 0.1 M phosphate buffer 
pH 7.4 at the potential window of +800 mV to -800 mV.  
 
Fig.17 shows the cyclic voltammogram of Cu(G2PPI)-co-PPy, where 3 faintly observable 
peaks are denoted by A, A
1
 and B. The oxidation state of copper in the complex was found to 
be +2 and the number of electrons that are found in the system were determined to be n=1. 
ΔEp [Ep,a – Ep,c ] was calculated for the polymer film grown at different scan rates resulted in 
a value of ΔEp lower than 65 mV as shown in table 2. This suggested that the polymer 
exhibited reversible and a fast electrochemistry. The cathodic peak at +146.36 mV denoted 
by (B) is seen to be increasing with an increase in scan rate. There is an observable cathodic 
shift in the peak potential to +55.79 mV due to the extended conjugation in the polymer 
which results in the lowering of the oxidation potential of the polymer. The anodic peak 
(+484.86 mV) denoted by (A) is due to the change in the oxidation state of the copper metal 
that is present in the copper complex as seen with the mechanism Cu
+ ↔   
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+ e
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no shift in the peak with an increase in scan rate, this is indicative of a surface bound species 
thus the (Cu(G2PPI)-co-PPy)copolymer is a surface bound species. There is an increase in 
the anodic peak currents of the (Cu(G2PPI)-co-PPy)which is indicative of the conductivity of 
the material. The cathodic peak (+435 mV) signified by (A
l
) is given by the mechanism 
Cu
2+
+ e
-
 
     ↔    Cu+. There was an increase in the cathodic current with an increase in scan 
rate. There was a slight increase in the cathodic peak and a broadening of the peak resulting 
in the plateau and disappearance of the peak at the scan rate of 80mV/s signifying a slow 
movement of the electron in the system. In Fig.18 it is indicated that the oxidation reaction 
occurring at Epa was diffusion controlled with correlation co-efficient of r
2
 = 0.9111 with a 
diffusion co-efficient which was found to be Do = 8.6374x 10
-5
 cm
2
/s; indicating a slower 
electron transfer kinetics within diffusion layer. However, the reduction current peak Epc had 
a correlation co-efficient of r
2 = 0.8976 indicating no linearity in the Randle Sevčik plot as a 
result of the fact that the reductive reaction  occurring at that potential was adsorption 
controlled rather than diffusion controlled, with a determined diffusion co-efficient of 5.5270 
x 10
-5
cm
2
/s. 
 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Randle Sevčik plots of  (Cu(G2PPI)-co-PPy)/Pt at different scan rates studied 
in 0.1 M PBS, pH 7.4 for determination of the diffusion co-efficient Do. 
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Table 2: Electrochemical studies of PPy and (Cu(G2PPI)-co-PPy)  
Polymer Epa 
(mV) 
Epc 
(mV) 
E
0
 
(mV) 
ΔEp = Epc - Epa 
(mV) 
n = 60/ΔEp Ipa/Ipc 
PPy 41.286 -24.156 83.35 90 1 2 
Cu(G2PPI)-co-PPy 
 
54.029 -36.02 90.04 60 2 2 
Cu(G2PPI) 54.00 -37.10 89.05 91 1 2 
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Figure 19: Cyclic voltammogram of PPy//Pt, Cu(G2PPI) and Cu(G2PPI)-co-PPy//Pt  in 
0.1M phosphate buffer pH 7.4 at 50 mV/s. 
Comparitive studies between PPy and (Cu(G2PPI)-co-PPy) represented by Fig.19 show that 
there is an observed increase in the formal potential (E
0
) for the (Cu(G2PPI)-co-PPy) system 
than the PPy system as illustrated in table 2, where (E
0
) was 90.04 mV, 89.05 mV and 83.35 
mV for (Cu(G2PPI)-co-PPy), Cu(G2PPI) and PPy respectively. There is also an increase in 
the observed peak current indicating that (Cu(G2PPI)-co-PPy) has better current resolution 
and thus is more conductive than PPy and Cu(G2PPI). This confirms that this co-polymer is a 
more suitable material for application in the construction of biosensors since it will function 
as a better electron mediator than Cu(G2PPI) and PPy alone.  
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Chapter 5 
Characterization of CYP 3A4 
nanobiosensor and detection of DLV 
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5.0 Summary  
 
This chapter deals with characterisation of the CYP 3A4/Pt and CYP 3A4/(Cu(G2PPI)-co-
PPy) /Pt and their response measurements using CV. 
 
 
Figure 20: Reaction scheme showing the metabolism of delavirdine using the 
CYP 3A4/(Cu(G2PPI)-co-PPy) /Pt nanobiosensor. 
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KEY: 
CYP 
4+, 3+, 2+
 - Different oxidation states of Cytochrome P450-3A4 
ROOH – delavirdine 
ROO-H – indole carboxylic acid 
 
N
H
O
N
N
N
N
N
H
HS
O
O
 
Delavirdine (A) 
 
 
HS
O
O
N
H
O
N
OH
 
    Indole carboxylic acid  (B)            
Figure 20(A) and (B) represnts the structures of delavirdine and indole carboxylic acid 
respectively.  
 
Fig.20 describes the binding of delavirdine drug onto the active site of the enzyme followed 
by the one electron electrochemical reduction of the hexa-coordinated low-spin ferric enzyme 
(Fe3+) to the high spin ferrous enzyme (Fe2+). This form of the enzyme has a high affinity 
for oxygen and thus binds molecular oxygen present in the solution onto the active site 
resulting in another electron reduction and formation of by-product. From the scheme in 
Fig.20  the compounds  RH and ROH are Delavirdine and Indole carboxylic acid 
respectively. 
 
 
 
 
 
 
56 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Cyclic voltammogram of the nanobiosensor at different scan rates ( 10, 20, 
30, 40, 50, 60, 70, 80 and 90 mV/s) in 0.1 M PBS pH 7.4. 
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Figure 22: Randle Sevčik plot of CYP 3A4/(Cu(G2PPI)-co-PPy)/Pt biosensor in 0.1M 
PBS pH 7.4 at different scan rates for the determination of the diffusion co-efficient. 
 
The voltammogram in Fig.21 shows an increase in current with an increase in scan rate. At 
lower scan rates (10 - 50mV/s) there is a linear increase in the current with an increase in 
scan rate. At scan rates from (60 - 90) mV/s there is a sharp increase in the current which is 
indicative of the instability in the nanobiosensor. In this context it is an indication of electron 
fouling thus the use of scan rates below 20 mV/s would be favourable for the studies using 
this nanobiosensor system to avoid such instance. Observed is a shift in the anodic potentials 
towards more oxidative potentials characteristic of a species which is more prone to 
oxidation. The peaks were characterised by the reduction peak at Epc = +403 mV is deduced 
to be due to the catalytic current produced by the nanobiosensor due to the presence of the 
enzyme.  The Randle Sevčik plot (Fig.22) show the linear dependency of the current on the 
scan rate. It indicated that the reduction reaction that was occurring at Ep = +403 mV was 
diffusion controlled with correlation co-efficient of r
2
 = 0.916 and the diffusion co-efficient 
was found to be Do = 6.917 x10
-5
 cm
2
/s, indicating a faster electron transfer kinetics within 
the diffusion layer of the nanobiosensor. However the oxidation peak current occurring at Epa 
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= +200 mV had a correlation co-efficient of r
2
 = 0.8908 indicating no linearity in the Randle 
Sevčik plots an adsorption controlled process is assumed, as opposed to diffusion controlled. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Cyclic voltammograms of the Pt electrode, CYP3A4/PtE and CYP3A4/ 
(Cu(G2PPI)-co-PPy)/PtE nanobiosensor in PBS pH 7.4. 
 
Fig.23 shows cyclic voltammograms of Pt electrode, CYP3A4/PtE and 
CYP3A4/(Cu(G2PPI)-co-PPy)/PtE modified onto platinum electrode in the absence of the 
analyte. There is a low peak current observed on the  CYP 3A4/PtE biosensor and an increase 
in the peak current on the CYP3A4/(Cu(G2PPI)-co-PPy)/PtE nanobiosensor which is 
indicative of the conductivity and catalytic activity of the (Cu(G2PPI)-co-PPy ) which 
facilitates the transfer of electrons. Although a catalytic reaction or the electron transfer 
reaction is possible between the enzyme and the electro active material within the bulk of the 
solution, this reaction will occur at a distance to the electrode surface. This is due to the fact 
that the stability of enzyme molecule onto the electrode surface is not good enough to hold 
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the enzyme in-close proximity to the electrode surface. Thus one would expect low 
electrochemical reactions, slow enough not to even be observed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: Cyclic voltammograms of the CYP 3A4/(Cu(G2PPI)-co-PPy)/Pt under 
aerobic and anaerobic conditions in 0.1M PBS PH 7.4 at scan rate 10 mV/s. 
 
The cyclic voltammograms represented in Fig.24 were obtained in the absence of the drug 
were performed in anaerobic and aerobic solutions. In the presence of oxygen, the 
nanobiosensor showed an increase in the cathodic and anodic peak current with an onset 
potential of -160 mV (vs Ag/AgCl) which is indicative of the oxygenation of CYP 3A4 heme 
Fe atom being coupled to the electron transfer reaction that occurs in argon degassed 
medium.  
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Figure 25: Cyclic voltammogram of the CYP3A4/(Cu(G2PPI)-co-PPy)/Pt nanobiosensor 
response of DLV drug in 0.1M PBS pH 7.4. 
 
The electrochemical behaviour of the nanobiosensor was evaluated using CV. CV was used 
to study the behaviour of the nanobiosensor to successive additions of delavirdine drug under 
aerobic conditions as shown in Fig.25. The presence of oxygen in the system is essential for 
the binding of oxygen to the heme group that is present in the CYP3A4 enzyme in the Fe
2+
 
state. In the absence of the analyte there is no oxidation and reduction peaks observed. With 
successive addition of the delavirdine drug there was an observed increase in the peak 
currents resulting from the current response generated by the electron transfer reaction 
occurring between the enzyme CYP3A4 immobilised and the substrate delavirdine. There 
was a slight shift in the potential towards positive potential values with an increase in 
substrate concentration which can be attributed to the conversion of Fe
4+
 oxidation state of 
the CYP 3A4 enzyme to Fe
3+ 
which can be attributed to the reduction of the CYP3A4 
enzyme by delavirdine. From the analyte concentration of 0.1 nM there was no observable 
change in the peak current which can be attributed to the saturation of the biosensor system 
where the analyte can no longer be bound on to the active site of the CYP 3A4. 
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From the linear range calibration curve for the CYP 3A4 detection  plot as seen in Fig.25 the 
limit of detection and sensitivity of the nanobiosensor towards delavirdine were estimated 
and calculated to be 0.025 nM and 0.379 μA/nM. The biosensor has a DLR of 0.01 nM – 
0.06 nM. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26: calibration curve from the linear range of hyperbolic curve for the 
determination of LOD. 
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Table 3: Detection limits for delavirdine by different detection methods. 
 
Detection technique LOD Reference 
A biosensor comprising enzyme CYP 
3A4 immobilized onto (Cu(G2PPI)-co-
PPy) star copolymer 
 
0.025 nM This study 
Delavirdine detection using HPLC 17μM Voorman, 2000 
Surface plasmon resonance biosensor 190 nM Elinder, 2010 
Isocratic reversed phase high-performance 
liquid chromatography with fluorescence 
detection 
1 nM Veldkamp, 1999 
 
Table 3 comprises of different detection techniques that can be used in the determination of 
delavirdine, the nanobiosesnor deviced in this study is the most practical device that can be 
used as it has the lowest detection limits than the other 3 techniques. This means that the 
(Cu(G2PPI)-co-PPy) star co-polymer-based nanbiosensor has the ability to detect 
concentrations as low as 0.025 nM which is a significantly low concentration that other 
techniques cannot detect.  
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Chapter 6 
Conclusion and recommendations 
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6.0 Summary 
 
This chapter revisits the specific objectives of the study to report whether the aims of this 
dissertation were achieved, and to give an overview of the success and shortcomings of the 
study.  
 
This study reports the successful development of a nanobiosensor which employed heme 
enzyme CYP3A4 for the detection of delavirdine a non nucleoside reverse transcriptase 
inhibitor anti HIV drug. The main objective of the study was to synthesize a copper poly 
(propylene imine)-co-poly pyrrole star copolymer through the functionalization of poly 
(propylene imine) dendrimer with pyrrole and to incorporate copper metal onto the 
functionalized poly (propylene imine); and use this as the platform of the nanobiosensor. 
Dendrimers and conducting polymers alike are attractive in their applications in the research 
of electrochemical biosensors due to their remarkable physicochemical and biological 
properties. In this study dendrimers have been used due to their porous structure which was 
suitable for the successful encapsulation and entrapment of copper nanoparticles and the 
enzyme CYP3A4. The conducting polymers and dendrimers enabled the immobilisation of 
the biological material (CYP3A4 enzyme) by providing a suitable microenvironment for 
biomolecules while retaining their biological activity by acting as a 3dimensional matrix.  It 
is encouraging to report that FTIR, HRSEM, HRTEM and EDS studies showed the 
successful incorporation of the copper metal into the dendrimer. The (Cu(G2PPI)-co-PPy) 
star co-polymer was formed by dropcoating copper poly propylene imine-2Pyrrole onto Pt 
working electrode followed by the electrochemical polymerization of pyrrole onto the 
electrode. Thorough the characterization of the star copolymer using FTIR, HRSEM, 
HRTEM, EDS and CV indicated a stable platform for the immobilization of the enzyme CYP 
3A4. The prepared star-co-polymer was used to serve as a point of attachment for the enzyme 
and act as a sufficient electron transfer mediator between the electrode surface and the redox 
enzyme centre of CYP 3A4. The results obtained from CV confirmed that the nanobiosensors 
was successful in the reductive catalysis of the delavirdine drug into respective water soluble 
and easy excretable metabolites. This is characterised by an observable increase in current for 
the analyte delavirdine. When the platform material was applied in the construction of the 
nanobiosensor, there was evidence of an increase in the current produced thus signifying 
excellent conductivity of the material ensuring good electron transfer within the system. This 
study is the first study to take advantage of the remarkable properties that are brought about 
by the combination of two polymer properties combined with a metal centre that has the 
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ability to act as a catalyst and source of electrons which are essential in the reduction process 
of delavirdine.Through the use of different characterisation techniques it was determined that 
(Cu(G2PPI)-co-PPy) star co-polymer was the best selection in the development of the 
nanobiosensor  signified by the following parameters; DLR, LOD and sensitivity of 0.01-0.06 
nM, 0.025 nM and 0.379 μA/nM respectively. The highest observed plasma concentration 
(Cmax) value of delavirdine found in plasma is 0.025-0.099 nM. The nanobiosensor developed 
in this study falls within the Cmax value of delavirine indicating that the developed 
nanobiosensor can be used successfully in human samples. These results are indicative of a 
good nanobiosensor that can detect very low drug concentrations amongst HIV/Aids patients 
and to assist in the determination of the metabolic profile of these patients and ensure that 
they are given a proper dosage based on their individual metabolic rates. 
 
In comparison to other studies using other techniques to determine the concentration of 
delavirdine such as HPLC and Surface plasmon resonance biosensor the (Cu(G2PPI)-co-PPy) 
star co-polymer-based nanbiosensor has the ability to detect concentrations as low as 0.025 
nM which is a significantly low concentration that other techniques cannot detect.  
 
  
6.1 Future work and Recommendations  
 
 Studies need to be thouroughly done of the starting polymer materials so that better 
comparison can be done with the co-polymer.  
 Square wave voltammetry experiments need to be performed aand coupled to cyclic 
voltammertry.  
 XRD needs to be done in order to corroborate with the FTIR findings to indicate 
whethere the lattice parameters might show a decrease due to Cu incorporation  
during heat treatment of the formed complexes to ascertain that no structural changes 
occurred after modification as stated. 
  Stability of the constructed biosensors need to be investigated. 
 
 The response time of the constructed biosensors need to be determined through the 
performance of steady state amperometry experiments. 
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